Medicine
ENTERO Vu 24% 240 mg/mL oral suspension
ENTERO Vu 24% 240 mg/mL oral suspension is a prescription medicine containing Barium sulfate for oral use, marketed by E-Z-EM Canada, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Store at USP controlled room temperature 20°C to 25°C…
Key facts
- Active ingredient (INN)
- Barium sulfate
- Brand
- ENTERO Vu 24%
- Strength
- 240 mg/mL
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 6 jug
- Marketing authorisation holder
- E-Z-EM Canada
- Manufacturer
- E-Z-EM Canada
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Store at USP controlled room temperature 20°C to 25°C (68°F to 77° F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 October 2020
- Identifiers
- DailyMed set ID 83a06a8e-93db-a59b-933c-5882127bce7cNDC 32909-146Application NDA208143
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 jug in 1 case / 600 mL in 1 jug | 32909-146-06 | E-Z-EM Canada | 1 October 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 11 January 2016 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Barium sulfate
Clinical summary
Barium sulfate is a radiographic contrast agent indicated in single contrast radiographic examinations of the esophagus, stomach, duodenum and small bowel to visualize the gastrointestinal tract (GI) in adult and pediatric patients. MedsAcross supplies Barium sulfate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Barium sulfateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- E-Z-Paque prescribing information (E-Z-EM Canada) · U.S. National Library of Medicine, DailyMed
Need ENTERO Vu 24% 240 mg/mL oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.